Related Experiment Video
Updated: Jun 14, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Single-cell multimodal analysis reveals the dynamic immunopathogenesis of HBV-ACLF progression
Xi Liang1, Jinjin Luo1, Qian Zhou1
1State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
This study reveals dynamic immune changes in Hepatitis B virus-related Acute-on-Chronic Liver Failure (HBV-ACLF), identifying specific immune cell patterns and potential therapeutic targets for precise patient management.
Area of Science:
- Immunology
- Hepatology
- Genomics
Background:
- Acute-on-chronic liver failure (ACLF) is a severe condition characterized by immune cell dysfunction.
- Hepatitis B virus (HBV) infection is a common cause of ACLF, leading to significant morbidity and mortality.
Purpose of the Study:
- To comprehensively map the dynamic immune response throughout the disease course of HBV-related ACLF.
- To identify specific immune cell subsets and their roles in disease progression and outcomes.
Main Methods:
- Employed single-cell RNA sequencing and proteomics on peripheral blood mononuclear cells from HBV-ACLF patients and controls.
- Validated findings through in vivo and in vitro functional experiments.
Main Results:
- Identified VCAN+CD14+ monocytes driving early inflammation and CXCR2+ neutrophils and CD163+ monocytes associated with disease deterioration.
- Observed impaired cytotoxic T-cells in progressive ACLF, with CXCR2+ neutrophils inducing T-cell exhaustion.
- Demonstrated therapeutic potential of CXCR2 inhibition in ACLF mouse models.
Conclusions:
- Revealed the dynamic immune evolution in HBV-ACLF through longitudinal multiomics.
- Characterized distinct immune patterns for precise management and therapeutic interventions in HBV-ACLF.
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022